×
About 448 results

ALLMedicine™ Allergy Immunotherapy Center

Research & Reviews  132 results

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass
https://clinicaltrials.gov/ct2/show/NCT04296474

Jun 24th, 2022 - Bakground: Intralymphatic immunotherapy has been proposed as a new, more effective, modality for allergy immunotherapy. With ultrasound- guided injections into the lymph node the allergen is injected directly to the secondary lymphoid organ to sti...

Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants
https://clinicaltrials.gov/ct2/show/NCT04104828

Mar 23rd, 2022 - This pilot study is an observational study with subsequent use of coded biological material. The blood sera are collected and prepared at the Allergy Units at the University Hospital Zurich (USZ) or Centre for Rhinology and Allergology Wiesbaden (...

Determining the minimal important differences in the RQLQ score with grass and tree all...
https://doi.org/10.1111/all.15207
Allergy Blaiss MS, Gronskyte Juhl R et. al.

Jan 6th, 2022 - Pollen from grasses and trees can trigger allergic rhinitis (AR), where the symptoms and associated consequences can negatively affect quality of life (QoL). The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) is frequently used in clinic...

Real-world evidence: Methods for assessing long-term health and effectiveness of allerg...
https://doi.org/10.1016/j.jaci.2021.12.781
The Journal of Allergy and Clinical Immunology; Fritzsching B, Contoli M et. al.

Jan 2nd, 2022 - Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy.|2022|Fritzsching B,Contoli M,Porsbjerg C,Buchs S,Larsen JR,|

Allergy immunotherapy from the patient's perspective.
https://doi.org/10.1002/alr.22898
International Forum of Allergy & Rhinology; Ballakur SS, An A et. al.

Sep 28th, 2021 - Allergy immunotherapy from the patient's perspective.|2021|Ballakur SS,An A,Toure M,Reisacher WR,|therapy,

see more →

Clinicaltrials.gov  12 results

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass
https://clinicaltrials.gov/ct2/show/NCT04296474

Jun 24th, 2022 - Bakground: Intralymphatic immunotherapy has been proposed as a new, more effective, modality for allergy immunotherapy. With ultrasound- guided injections into the lymph node the allergen is injected directly to the secondary lymphoid organ to sti...

Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants
https://clinicaltrials.gov/ct2/show/NCT04104828

Mar 23rd, 2022 - This pilot study is an observational study with subsequent use of coded biological material. The blood sera are collected and prepared at the Allergy Units at the University Hospital Zurich (USZ) or Centre for Rhinology and Allergology Wiesbaden (...

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
https://clinicaltrials.gov/ct2/show/NCT02014623

Oct 14th, 2020 - Allergic diseases represent a major health issue worldwide and epidemiological studies in Melbourne, Australia, have reported a high prevalence of rhinitis (hayfever) and atopy (genetic tendency to make allergy antibody) in Asian and Caucasian sub...

Allergy Immunotherapy for the Reduction of Asthma
https://clinicaltrials.gov/ct2/show/NCT01028560

May 28th, 2019 - In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who are at high risk for developing persisting asthma. These risk...

Microassay and Allergy Skin Prick Test Correlation Study
https://clinicaltrials.gov/ct2/show/NCT03514303

Oct 17th, 2018 - Prospective subjects for study entry will initially be screened by the results of their allergy skin test that were acquired within the past two years. In order to be a prospective subject positive SPT results of five of the following ten allergen...

see more →

News  35 results

Oral Immunotherapy: Psychological Support Improves Treatment Success
https://www.medscape.com/viewarticle/969956

Mar 9th, 2022 - Oral immunotherapy (OIT) is a promising long-term food allergy regimen, but it can be so stressful that patients often quit. Providing young patients and their families with psychological support can increase the odds that they'll complete the ful...

Debate Continues Over Multiallergen Subcutaneous Immunotherapy
https://www.medscape.com/viewarticle/963870

Nov 30th, 2021 - A resolution is needed in the ongoing controversy between US and European allergists over the best approach to subcutaneous allergy immunotherapy (SCIT), "since it is likely that one or the other group of patients is receiving sub-optimal treatmen...

There's a Much Safer Food Allergy Immunotherapy. Why Don't More Doctors Offer It?
https://www.medscape.com/viewarticle/954302

Jul 7th, 2021 - This is part 1 of a three-part series. Part 2 is here. Part 3 is here. For the 32 million people in the United States with food allergies, those who seek relief beyond constant vigilance and EpiPens face a confusing treatment landscape. In January...

FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost
https://www.medscape.com/viewarticle/941016

Nov 15th, 2020 - Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it will be widely adopted has yet to be determined. A few dozen allergists aro...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.staging.medscape.com/viewarticle/928035

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

see more →